{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-24-022624","form_type":"8-K","ticker":"PPCB","cik":"0001517681","company_name":"Propanc Biopharma, Inc.","filed_at":"2024-06-05T23:59:59+00:00","discovered_at":"2026-05-14T18:03:18.785886+00:00","generated_at":"2026-06-01T06:15:03.215432+00:00","sec_items":["1.01","2.03","3.02","9.01"],"event_type":"debt","sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.35,"confidence":"high","headline":"Propanc Biopharma closes $49,200 convertible note financing with 15% interest, net $41,000","bullets":["Entered securities purchase agreement with 1800 Diagonal Lending LLC for $49,200 convertible note; purchase price $41,000 (includes $8,200 OID).","Note matures March 30, 2025; one-time 15% interest, total payback $56,580 due in five installments starting Nov 30, 2024.","Upon event of default, investor may convert at 65% of lowest trading price in prior 10 days (35% discount).","Proceeds used for general working capital; issuance exempt under Section 4(a)(2) and Rule 506 of Regulation D.","Company has approximately 183.3 million shares of common stock outstanding as of May 22, 2024."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-24-022624","json":"https://secwatch.observer/filing/0001493152-24-022624.json","markdown":"https://secwatch.observer/filing/0001493152-24-022624.md","text":"https://secwatch.observer/filing/0001493152-24-022624.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1517681/000149315224022624/0001493152-24-022624-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1517681/000149315224022624/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-01T06:15:03.215432+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}